发明名称 ACYLATED ARYLCYCLOALKYLAMINES AND THEIR USE AS PHARMACEUTICALS
摘要 The present invention relates to acylated arylcycloalkylamines of the formula I, in which R1, R2 and n have the meanings indicated in the claims. The compounds of formula I are valuable pharmacologically active compounds which are useful in the treatment of various disease states including cardiovascular disorders such as atherosclerosis, thrombosis, coronary artery disease, hypertension and cardiac insufficiency. They upregulate the expression of the enzyme endothelial nitric oxide (NO) synthase and can be applied in conditions in which an increased expression of said enzyme or an increased NO level or the normalization of a decreased NO level is desired. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
申请公布号 CA2494628(C) 申请公布日期 2011.12.13
申请号 CA20032494628 申请日期 2003.07.24
申请人 AVENTIS PHARMA DEUTSCHLAND GMBH 发明人 STROBEL, HARTMUT;WOHLFART, PAULUS;BELOW, PETER
分类号 C07C233/58;C07D295/14;A61K31/166;A61K31/18;A61K31/381;A61K31/40;A61K31/4025;A61K31/4184;A61K31/421;A61K31/426;A61K31/44;A61K31/47;A61K31/4965;A61K31/5375;A61K31/5377;A61P1/16;A61P3/10;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/12;A61P15/10;A61P19/10;A61P27/02;C07C233/65;C07C237/38;C07C311/08;C07C311/21;C07D209/08;C07D211/14;C07D213/82;C07D215/54;C07D231/14;C07D235/08;C07D241/24;C07D241/26;C07D263/34;C07D277/20;C07D277/56;C07D295/155;C07D333/38;C07D401/04;C07D409/04;C07D409/06 主分类号 C07C233/58
代理机构 代理人
主权项
地址
您可能感兴趣的专利